文献速递外周动脉疾病

慢性肢体威胁性缺血腔内治疗后双功超声监测的随机临床试验

Randomized clinical trial of duplex ultrasound surveillance after endovascular therapy for chronic limb-threatening ischemia.
PubMed 文献 · J Vasc Surg · 2025-08-05

单中心随机对照试验纳入203例慢性肢体威胁性缺血(CLTI)患者,比较股腘动脉腔内治疗(EVT)后双功超声(DUS)监测与踝肱指数(ABI)监测的结局。DUS组股腘动脉一期辅助通畅率(PAP)和二期通畅率(SP)显著优于ABI组,但无截肢生存率(AFS)、总生存率(OS)和无再干预率(FFR)无差异。

要点

  • CLTI患者股腘动脉EVT后DUS监测较ABI监测提高PAP和SP。
  • 两组AFS、OS和FFR无统计学差异。
  • DUS监测可能有助于优化EVT术后随访策略。

核心结论

  • CLTI患者股腘动脉EVT后DUS监测较ABI监测显著改善PAP和SP,但AFS、OS和FFR无差异。

研究设计与样本

  • 单中心随机对照试验,2018年3月至2021年1月连续纳入203例接受腹股沟下EVT的CLTI患者,随机分为ABI组(n=103)和DUS组(n=100)。

关键数值与推荐

  • 主要终点为股腘动脉PAP、SP和AFS率,次要终点包括OS和FFR率。
  • 术后1、3、6、9、12个月及之后每6个月随访。
  • 平均随访517天(95%CI 440-574天),生存曲线随访时间540天。

临床怎么用

  • CLTI患者腹股沟下EVT后可采用DUS监测以提高股腘动脉PAP和SP。
  • DUS监测未显示改善AFS、OS和FFR,需综合评估患者情况选择监测方式。

局限性

  • 单中心研究,样本量有限,结论外推需谨慎。
  • 早期术后30天内185例存活且治疗段通畅者进入研究,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to assess whether duplex ultrasound (DUS) surveillance yielded a better outcome compared with ankle-brachial index (ABI) surveillance after femoropopliteal endovascular therapy (EVT) in a cohort of patients affected by chronic limb-threatening ischemia (CLTI). METHODS: A single-center randomized controlled trial was conducted on consecutive admissions of patients with CLTI who underwent infra-inguinal EVT between March 2018 and January 2021. On the day after the operation, 203 patients were randomized to the ABI group (n = 103) or DUS group (n = 100) for follow-up at 1, 3, 6, 9, and 12 months, and every 6 months thereafter. The primary endpoint was femoropopliteal primary assisted patency (PAP), secondary patency (SP), and amputation-free survival (AFS) rates, and secondary endpoints included overall survival (OS) and freedom from reintervention (FFR) rates. Survival curves were presented as Kaplan-Meier plots. Log-rank tests were performed to compare the differences between the groups. RESULTS: After the early postprocedural period (≤30 days), 185 patients alive with a patent treated segment remained in the study (ABI group, n = 98; DUS group, n = 87). The average age was 72.3 years (55.7% female; 84.3% had hypertension; 81% had diabetes; and 88.6% had tissue loss). The overall mean follow-up period was 517 days (95% confidence interval, 440-574 days), with no statistical differences between the groups. Survival curves using the Kaplan-Meier method were reported considering a follow-up time of 540 days. There were no statistical differences in primary patency rate between the ABI group and the DUS group (56% vs 59%, respectively; P = .30). However, there was a statistical difference between the groups in PAP rate (67% vs 78%, respectively; P = .04) and SP rate (78% vs 86%, respectively; P = .02). There were no statistically significant differences between the groups in AFS rate (69% vs 82%, respectively; P = .07), OS rate (73% vs 83%, respectively; P = .20), and in FFR rate (66% vs 65%, respectively; P = 1.0). CONCLUSIONS: This single-center randomized controlled trial of patients with CLTI showed a significant benefit in terms of improved femoropopliteal PAP and SP rates in patients who underwent follow-up with DUS surveillance after infra-inguinal EVT; however, there was no difference in AFS, OS, and FFR rates between the groups. Our findings may contribute to the more comprehensive use of DUS surveillance after endovascular revascularization.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Godoy MR, Brochado-Neto FC, Martins Cury MV, et al. Randomized clinical trial of duplex ultrasound surveillance after endovascular therapy for chronic limb-threatening ischemia. J Vasc Surg. 2025. PMID: 40752771. doi:10.1016/j.jvs.2025.07.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。